Humana Shares Up 6% on Q4 Beat and Better Outlook
<p><a href='https://financialmodelingprep.com/financial-summary/HUM'>Humana Inc. (NYSE:HUM)</a> shares closed more than 6% higher on Thursday following the company’s Q4 results, with $1.24 of EPS coming in above the Street estimate of $1.16.</p>
<p>According to the company’s management, COVID costs in individual Medicare were around 1% below baseline, roughly in line with expectations. Management also noted that in late Q4 and early Q1 COVID costs are exceeding expectations, but that is being offset by lower non-COVID costs.</p>
<p>The company provided its 2022 outlook expecting at least $24.00 EPS, compared to the consensus estimate of $23.89. The outlook assumes a conservative $1.00/share COVID headwind, which could lead to upside to results. In addition, the outlook absorbs the recently discussed enrollment pressure, which is being offset by 50 bps of margin expansion. </p>

NYSE:HUM